DJBP Activators
DJBP Activators are a class of compounds that enhance the functional activity of the DJBP protein through various biochemical and cellular pathways. Forskolin, by raising intracellular cAMP levels, can indirectly enhance DJBP's function by promoting the activation of PKA, which in turn may phosphorylate substrates that modulate transcription factors interacting with DJBP. PMA's activation of PKC similarly has the potential to enhance DJBP's role in signaling pathways through the phosphorylation of proteins that could be part of the DJBP regulatory network. Compounds like Epigallocatechin gallate and 5-Aza-2'-deoxycytidine, by modifying the epigenetic landscape, can enhance DJBP's ability to regulate gene expression, potentially altering the transcriptional programs that DJBP influences. Sodium butyrate and Trichostatin A, as histone deacetylase inhibitors, can lead to a more open chromatin state, potentially enhancing the regulatory functions of DJBP in gene expression by increasing the accessibility of transcriptional machinery to DNA.
The functional mechanisms of DJBP can also be influenced by compounds that modify signaling cascades and cellular stress responses.Compounds such as LY294002 and SP600125, which target PI3K and JNK pathways respectively, may enhance DJBP's function by altering the signaling networks and stress response elements that DJBP might regulate. By influencing these pathways, these inhibitors could lead to an adjusted cellular context where DJBP's activity is upregulated. Similarly, SB203580's inhibition of p38 MAPK can modulate inflammatory and stress response signaling, potentially enhancing DJBP's role within these pathways. Ionomycin, by increasing intracellular calcium levels, could enhance DJBP's involvement in calcium-dependent signaling processes. Roscovitine's inhibition of cyclin-dependent kinases has the potential to enhance DJBP's role in cell cycle regulation, while S3I-201's interference with STAT3 dimerization may enable an environment where DJBP's regulatory influence on gene expression is enhanced.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular levels of cAMP. Elevated cAMP can enhance protein kinase A (PKA) activity, which can phosphorylate proteins involved in the regulation of transcription factors, potentially enhancing DJBP's function in transcriptional regulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in signal transduction and may enhance phosphorylation of proteins that interact with DJBP, facilitating its function in cellular signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits DNA methyltransferases, potentially affecting DNA methylation patterns and chromatin structure, which may enhance DJBP's role in epigenetic regulation of gene expression. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent signaling pathways, indirectly enhancing DJBP's function in calcium-mediated cellular processes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor, which leads to increased acetylation of histones, potentially enhancing DJBP's function in the regulation of chromatin remodeling and gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor; by inhibiting PI3K, it can alter downstream signaling pathways such as AKT, potentially affecting cellular processes that could enhance DJBP's function in signaling cascades. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that can modify the JNK signaling pathway, potentially enhancing DJBP's function by influencing proteins that interact with DJBP in stress response pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may affect the MAPK signaling pathway, potentially enhancing DJBP's function by altering the phosphorylation state of proteins that interact with DJBP in inflammation and stress response. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase inhibitor, which could enhance DJBP's function by affecting cell cycle regulation and transcriptional control mechanisms in which DJBP is involved. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2'-deoxycytidine is a DNA methyltransferase inhibitor, potentially enhancing DJBP's function by altering gene expression patterns through epigenetic modifications. | ||||||